Prime Medicine is a gene editing biotechnology company.

Register for Details

For more details on financing and valuation for Prime Medicine, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Prime Medicine

Forge green plus iconForge green minus icon

What is Prime Medicine's IPO price?

Prime Medicine's IPO price is $6.39 as of 1/18/24.
Forge green plus iconForge green minus icon

What is Prime Medicine's funding to date?

Prime Medicine has raised $315.76MM to date.
Forge green plus iconForge green minus icon

When was Prime Medicine founded?

Prime Medicine was founded in 2019.

Prime Medicine Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
7/13/2021 Series B $200MM raised $XXX.XX $XXX.XX
10/15/2020 Series A $115.76MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.